SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-Q

QUARTERLY REPORT PURSUANT TO SECTION 17 OF THE SECURITIES
REGULATION CODE AND SRC RULE 17(2)(b) THEREUNDER

1. For the quarterly period ended

Jun 30, 2022

2. SEC Identification Number

CS200251064

3. BIR Tax Identification No.

219075614

4. Exact name of issuer as specified in its charter

MEDILINES DISTRIBUTORS INCORPORATED

5. Province, country or other jurisdiction of incorporation or organization

Metro Manila, Philippines

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

3rd Floor, Vistamall Hub, C.V. Starr Ave., Pamplona Dos, Las Pinas City Postal Code 1740

8. Issuer's telephone number, including area code

+6377471076/+6385192012

9. Former name or former address, and former fiscal year, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common	2,750,000,800

11. Are any or all of registrant's securities listed on a Stock Exchange?

Yes

No

If yes, state the name of such stock exchange and the classes of securities listed therein:

Philippine Stock Exchange

12. Indicate by check mark whether the registrant:

(a) has filed all reports required to be filed by Section 17 of the SRC and SRC Rule 17 thereunder or Sections 11 of the RSA and RSA Rule 11(a)-1 thereunder, and Sections 26 and 141 of the Corporation Code of the Philippines, during the preceding twelve (12) months (or for such shorter period that the registrant was required to file such reports)

Yes

No

(b) has been subject to such filing requirements for the past ninety (90) days

Yes

No

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Medilines Distributors IncorporatedMEDIC

PSE Disclosure Form 17-2 - Quarterly Report References: SRC Rule 17 and
Sections 17.2 and 17.8 of the Revised Disclosure Rules

For the period ended	Jun 30, 2022
Currency (indicate units, if applicable)	Php

Balance Sheet

	Period Ended	Fiscal Year Ended (Audited)
	Jun 30, 2022	Dec 31, 2021
Current Assets	3,478,675,411	3,814,720,205
Total Assets	3,650,892,039	3,985,872,621
Current Liabilities	1,633,931,466	1,968,884,293
Total Liabilities	1,646,122,454	2,045,094,953
Retained Earnings/(Deficit)	233,198,276	171,441,619
Stockholders' Equity	2,004,769,585	1,940,777,668
Stockholders' Equity - Parent	2,004,769,585	1,940,777,668
Book Value per Share	0.73	0.71

Income Statement

	Current Year (3 Months)	Previous Year (3 Months)	Current Year-To-Date	Previous Year-To-Date
Gross Revenue	595,008,902	616,608,588	854,872,578	815,089,992
Gross Expense	530,978,445	524,979,974	753,926,825	704,203,039
Non-Operating Income	5,948,742	27,946,601	6,994,335	19,539,672
Non-Operating Expense	-	-	-	-
Income/(Loss) Before Tax	69,979,198	119,575,215	107,940,088	130,426,625
Income Tax Expense	17,494,800	27,668,229	26,985,022	30,381,082
Net Income/(Loss) After Tax	52,484,399	91,906,985	80,955,066	100,045,543
Net Income Attributable to Parent Equity Holder	52,484,399	91,906,985	80,955,066	100,045,543
Earnings/(Loss) Per Share (Basic)	0.02	0.03	0.03	0.04
Earnings/(Loss) Per Share (Diluted)	0.02	0.03	0.03	0.04

	Current Year (Trailing 12 months)	Previous Year (Trailing 12 months)
Earnings/(Loss) Per Share (Basic)	0.03	0.04
Earnings/(Loss) Per Share (Diluted)	0.03	0.04

Other Relevant Information
Please see attached the Company's 17-Q for the second quarter of 2022